KD,app binding constants measured for WT and mutant GPVI-Fc binding to collagenous substrates in solid-phase plate-binding assays
Mutant . | CRP . | Fibrillar collagen I . | Toolkit peptide III-30 . | ||||||
---|---|---|---|---|---|---|---|---|---|
KD,app (nM) . | 95% CI (nM) . | Fold increase . | KD,app (nM) . | 95% CI (nM) . | Fold increase . | KD,app (nM) . | 95% CI (nM) . | Fold increase . | |
WT | 2.71 | 2.2-3.2 | 30.1 | 26-34 | 10.9 | 9.7-12.0 | |||
E40A | 2.5 × 103 | 2.1-2.8 × 103 | 913 | 25 × 103 | 22.1-27.5 × 103 | 823 | 74 × 103 | 57-91 × 103 | 6848 |
R38A | 2.0 × 103 | 1.7-2.3 × 103 | 748 | 18 × 103 | 16.0-20.3 × 103 | 603 | 42 × 103 | 38-45 × 103 | 3833 |
W76A | 2.0 × 103 | 1.8-2.2 × 103 | 744 | 43 × 103 | 37.2-49.6 × 103 | 1440 | 21 × 103 | 14-27 × 103 | 1905 |
D49A | 599 | 454-744 | 221 | 9.2 × 103 | 8.03-10.4 × 103 | 306 | 3.9 × 103 | 3.55-4.19 × 103 | 357 |
R67A | 238 | 187-289 | 88 | 10 × 103 | 6.63-12.9 × 103 | 324 | 2.0 × 103 | 1.90-2.16 × 103 | 187 |
Y47A | 160 | 130-189 | 59 | 6.0 × 103 | 4.43-7.56 × 103 | 199 | 10 × 103 | 8.5-12 × 103 | 925 |
S69A | 45.7 | 24-67 | 17 | 1.2 × 103 | 0.93-1.49 × 103 | 40 | 6.5 × 103 | 5.66-7.40 × 103 | 602 |
Q71A | 19.9 | 11-29 | 7 | 72.2 | 54.8-89.5 | 2 | 9.15* | 6.87-11.4 | 0.84 |
L36A | 18.8 | 12-25 | 7 | 186 | 150-222 | 6 | 7.68* | 5.77-9.58 | 0.70 |
Q82A | 3.89 | 2.5-5.3 | 1.4 | 433 | 329-538 | 14 | 289 | 268-310 | 27 |
Mutant . | CRP . | Fibrillar collagen I . | Toolkit peptide III-30 . | ||||||
---|---|---|---|---|---|---|---|---|---|
KD,app (nM) . | 95% CI (nM) . | Fold increase . | KD,app (nM) . | 95% CI (nM) . | Fold increase . | KD,app (nM) . | 95% CI (nM) . | Fold increase . | |
WT | 2.71 | 2.2-3.2 | 30.1 | 26-34 | 10.9 | 9.7-12.0 | |||
E40A | 2.5 × 103 | 2.1-2.8 × 103 | 913 | 25 × 103 | 22.1-27.5 × 103 | 823 | 74 × 103 | 57-91 × 103 | 6848 |
R38A | 2.0 × 103 | 1.7-2.3 × 103 | 748 | 18 × 103 | 16.0-20.3 × 103 | 603 | 42 × 103 | 38-45 × 103 | 3833 |
W76A | 2.0 × 103 | 1.8-2.2 × 103 | 744 | 43 × 103 | 37.2-49.6 × 103 | 1440 | 21 × 103 | 14-27 × 103 | 1905 |
D49A | 599 | 454-744 | 221 | 9.2 × 103 | 8.03-10.4 × 103 | 306 | 3.9 × 103 | 3.55-4.19 × 103 | 357 |
R67A | 238 | 187-289 | 88 | 10 × 103 | 6.63-12.9 × 103 | 324 | 2.0 × 103 | 1.90-2.16 × 103 | 187 |
Y47A | 160 | 130-189 | 59 | 6.0 × 103 | 4.43-7.56 × 103 | 199 | 10 × 103 | 8.5-12 × 103 | 925 |
S69A | 45.7 | 24-67 | 17 | 1.2 × 103 | 0.93-1.49 × 103 | 40 | 6.5 × 103 | 5.66-7.40 × 103 | 602 |
Q71A | 19.9 | 11-29 | 7 | 72.2 | 54.8-89.5 | 2 | 9.15* | 6.87-11.4 | 0.84 |
L36A | 18.8 | 12-25 | 7 | 186 | 150-222 | 6 | 7.68* | 5.77-9.58 | 0.70 |
Q82A | 3.89 | 2.5-5.3 | 1.4 | 433 | 329-538 | 14 | 289 | 268-310 | 27 |
Maximum III-30-binding of the Q71A and L36A mutants is 109% (104-114%) compared with WT protein.